Qlik® announced the results of the inaugural BARC Benchmark, an independent study evaluating business intelligence ...

Keysight Technologies, Inc. (NYSE: KEYS) announced a new series of high-power ATE system power supplies, expanding its power test portfolio with three automated test equipment (ATE) product families: ...

The program has, to date, assisted some 1,000 residents of the City of Brotherly Love to create wills. Since 2022, Philadelphia’s Will Power Program has connected residents like 72-year-old Vendetta ...

More than 20 states sued the Environmental Protection Agency on Thursday, challenging the agency’s decision to cancel a $7 billion program that aimed to make solar power accessible to low-income ...

The biggest portable generators for the U.S. military these days have an output of about 800 kilowatts. While that might be enough to power major systems, the weapons and radar of the future are ...

The Army is launching a sweeping new nuclear program to generate power for bases across the globe, particularly in remote or contested locations where fuel might be difficult to obtain, Fox News ...

POWERGEN, the premier event for power generation professionals, is excited to announce that the 2026 Technical Conference Program is now live. Scheduled for January 20–22, 2026, at the Henry B.

The justices are set to hear cases on tariffs, voting rights and trans athletes President Donald Trump has been on a roll at the U.S. Supreme Court, winning more than a dozen interim rulings backing ...

San Diego Community Power Wednesday announced a program intended to make solar power more affordable for thousands of San Diego County residents while strengthening the region's power grid. SDCP, a ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Over the past few years, content has become a cornerstone of the modern marketing strategy.

Xencor remains a "Strong Buy" rating due to progress in its bispecific and monospecific antibody pipeline targeting inflammatory disorders and cancer. XNCR's XmAb942 anti-TL1A antibody is advancing ...